Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Editorial

  • Editorial
    Can a Single Pill Replace Doublet Chemotherapy in First-Line Therapy of Advanced Non–Small Cell Lung Cancer?
    Paul A. Bunn Jr.
    Clin Cancer Res October 15 2006 12 (20) 5919-5920; DOI:10.1158/1078-0432.CCR-06-1553

The Biology Behind

  • The Biology Behind
    Natural Killer T Cell–Based Cancer Immunotherapy
    Hans J.J. van der Vliet, Steven P. Balk and Mark A. Exley
    Clin Cancer Res October 15 2006 12 (20) 5921-5923; DOI:10.1158/1078-0432.CCR-06-1392

Molecular Pathways

  • Molecular Pathways
    The Hedgehog Signaling Pathway in Cancer
    Marie Evangelista, Hua Tian and Frederic J. de Sauvage
    Clin Cancer Res October 15 2006 12 (20) 5924-5928; DOI:10.1158/1078-0432.CCR-06-1736

Special Article

  • Special Article
    The FLIP-Side of Fas Signaling
    Marc L. Hyer, Temesgen Samuel and John C. Reed
    Clin Cancer Res October 15 2006 12 (20) 5929-5931; DOI:10.1158/1078-0432.CCR-06-2098

Human Cancer Biology

  • Human Cancer Biology
    PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia
    Monica Prasad Hayes, Hong Wang, Rosanny Espinal-Witter, Wayne Douglas, Garron J. Solomon, Suzanne J. Baker and Lora Hedrick Ellenson
    Clin Cancer Res October 15 2006 12 (20) 5932-5935; DOI:10.1158/1078-0432.CCR-06-1375

  • Human Cancer Biology
    Met Receptor Signaling: A Key Effector in Esophageal Adenocarcinoma
    Mark R. Anderson, Rebecca Harrison, Paul A. Atherfold, Moray J. Campbell, S. Jane Darnton, Jolanta Obszynska and Janusz A.Z Jankowski
    Clin Cancer Res October 15 2006 12 (20) 5936-5943; DOI:10.1158/1078-0432.CCR-06-1208

  • Human Cancer Biology
    Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma
    Ben Davidson, Zhen Zhang, Lilach Kleinberg, Mei Li, Vivi Ann Flørenes, Tian-Li Wang and Ie-Ming Shih
    Clin Cancer Res October 15 2006 12 (20) 5944-5950; DOI:10.1158/1078-0432.CCR-06-1059

  • Human Cancer Biology
    GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1
    Yu Wen, Sarah F. Giardina, David Hamming, Jennifer Greenman, Emmanuel Zachariah, Manny D. Bacolod, Hao Liu, Jinru Shia, Peter S. Amenta, Francis Barany, Phillip Paty, William Gerald and Daniel Notterman
    Clin Cancer Res October 15 2006 12 (20) 5951-5959; DOI:10.1158/1078-0432.CCR-06-0736

  • Human Cancer Biology
    Identification of a Gene Signature for Rapid Screening of Oral Squamous Cell Carcinoma
    Amy F. Ziober, Kirtesh R. Patel, Faizan Alawi, Phyllis Gimotty, Randall S. Weber, Michael M. Feldman, Ara A. Chalian, Gregory S. Weinstein, Jennifer Hunt and Barry L. Ziober
    Clin Cancer Res October 15 2006 12 (20) 5960-5971; DOI:10.1158/1078-0432.CCR-06-0535

  • Human Cancer Biology
    Carcinoembryonic Antigen Messenger RNA Expression in Blood Predicts Recurrence in Esophageal Cancer
    Tetsuro Setoyama, Shoji Natsugoe, Hiroshi Okumura, Masataka Matsumoto, Yasuto Uchikado, Sumiya Ishigami, Tetsuhiro Owaki, Sonshin Takao and Takashi Aikou
    Clin Cancer Res October 15 2006 12 (20) 5972-5977; DOI:10.1158/1078-0432.CCR-06-0637

  • Human Cancer Biology
    The Potential of BORIS Detected in the Leukocytes of Breast Cancer Patients as an Early Marker of Tumorigenesis
    Vivien D'Arcy, Ziedulla K. Abdullaev, Naresh Pore, France Docquier, Verónica Torrano, Igor Chernukhin, Melissa Smart, Dawn Farrar, Metodi Metodiev, Nelson Fernandez, Carlos Richard, M. Dolores Delgado, Victor Lobanenkov and Elena Klenova
    Clin Cancer Res October 15 2006 12 (20) 5978-5986; DOI:10.1158/1078-0432.CCR-05-2731

  • Human Cancer Biology
    Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer
    Llana Pootrakul, Ram H. Datar, Shan-Rong Shi, Jie Cai, Debra Hawes, Susan G. Groshen, Amy S. Lee and Richard J. Cote
    Clin Cancer Res October 15 2006 12 (20) 5987-5993; DOI:10.1158/1078-0432.CCR-06-0133

  • Human Cancer Biology
    Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma Cells
    Kazufumi Ohshiro, Suresh K. Rayala, Michelle D. Williams, Rakesh Kumar and Adel K. El-Naggar
    Clin Cancer Res October 15 2006 12 (20) 5994-5999; DOI:10.1158/1078-0432.CCR-06-1251

  • Human Cancer Biology
    The Novel p21 Polymorphism p21G251A Is Associated with Locally Advanced Breast Cancer
    Vidar Staalesen, Stian Knappskog, Ranjan Chrisanthar, Silje H. Nordgard, Erik Løkkevik, Gun Anker, Bjørn Østenstad, Steinar Lundgren, Terje Risberg, Ingvil Mjaaland, Inger Torhild Gram, Vessela N. Kristensen, Anne-Lise Børresen-Dale, Johan Richard Lillehaug and Per Eystein Lønning
    Clin Cancer Res October 15 2006 12 (20) 6000-6004; DOI:10.1158/1078-0432.CCR-05-2822

  • Human Cancer Biology
    A Homeobox Protein, Prox1, Is Involved in the Differentiation, Proliferation, and Prognosis in Hepatocellular Carcinoma
    Masayuki Shimoda, Meiko Takahashi, Takanobu Yoshimoto, Tomoya Kono, Iwao Ikai and Hajime Kubo
    Clin Cancer Res October 15 2006 12 (20) 6005-6011; DOI:10.1158/1078-0432.CCR-06-0712

  • Human Cancer Biology
    Glucocorticoids Suppress Tumor Lymphangiogenesis of Prostate Cancer Cells
    Akihiro Yano, Yasuhisa Fujii, Aki Iwai, Satoru Kawakami, Yukio Kageyama and Kazunori Kihara
    Clin Cancer Res October 15 2006 12 (20) 6012-6017; DOI:10.1158/1078-0432.CCR-06-0749

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy
    Jonathan R. Reeves, Hélène Dulude, Chandra Panchal, Luc Daigneault and Dharam M. Ramnani
    Clin Cancer Res October 15 2006 12 (20) 6018-6022; DOI:10.1158/1078-0432.CCR-06-0625

  • Imaging, Diagnosis, Prognosis
    Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma
    Berthold Streubel, Daniela Huber, Stefan Wöhrer, Andreas Chott and Markus Raderer
    Clin Cancer Res October 15 2006 12 (20) 6023-6028; DOI:10.1158/1078-0432.CCR-06-0232

  • Imaging, Diagnosis, Prognosis
    The p53 Pathway and Outcome among Patients with T1G3 Bladder Tumors
    Elena López-Knowles, Silvia Hernández, Manolis Kogevinas, Josep Lloreta, Alex Amorós, Adonina Tardón, Alfredo Carrato, Sirish Kishore, Consol Serra, Núria Malats and Francisco X. Real
    Clin Cancer Res October 15 2006 12 (20) 6029-6036; DOI:10.1158/1078-0432.CCR-06-0206

  • Imaging, Diagnosis, Prognosis
    Functional Plasminogen Activator Inhibitor-1 Gene Variants and Breast Cancer Survival
    Xianglan Zhang, Xiao-Ou Shu, Qiuyin Cai, ZhiXian Ruan, Yu-Tang Gao and Wei Zheng
    Clin Cancer Res October 15 2006 12 (20) 6037-6042; DOI:10.1158/1078-0432.CCR-05-2851

  • Imaging, Diagnosis, Prognosis
    Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer
    Hirokazu Uyama, Yasuhiko Tomita, Hideji Nakamura, Shoji Nakamori, Binglin Zhang, Yoshihiko Hoshida, Hirayuki Enomoto, Yorihide Okuda, Masato Sakon, Katsuyuki Aozasa, Ichiro Kawase, Norio Hayashi and Morito Monden
    Clin Cancer Res October 15 2006 12 (20) 6043-6048; DOI:10.1158/1078-0432.CCR-06-1064

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study
    Giuseppe Giaccone, Marielle Gallegos Ruiz, Thierry Le Chevalier, Nick Thatcher, Egbert Smit, Jose Antonio Rodriguez, Pasi Janne, Dalila Oulid-Aissa and Jean-Charles Soria
    Clin Cancer Res October 15 2006 12 (20) 6049-6055; DOI:10.1158/1078-0432.CCR-06-0260

  • Cancer Therapy: Clinical
    Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients
    Stephen M. Ansell, Susan M. Geyer, Matthew J. Maurer, Paul J. Kurtin, Ivana N.M. Micallef, Philip Stella, Paul Etzell, Anne J. Novak, Charles Erlichman and Thomas E. Witzig
    Clin Cancer Res October 15 2006 12 (20) 6056-6063; DOI:10.1158/1078-0432.CCR-06-1245

  • Cancer Therapy: Clinical
    A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus
    Bernard M. Tijink, Jan Buter, Remco de Bree, Giuseppe Giaccone, Margreet S. Lang, Alexander Staab, C. René Leemans and Guus A.M.S. van Dongen
    Clin Cancer Res October 15 2006 12 (20) 6064-6072; DOI:10.1158/1078-0432.CCR-06-0910

  • Cancer Therapy: Clinical
    Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors
    Catherine Delbaldo, Etienne Chatelut, Micheline Ré, Alain Deroussent, Sophie Séronie-Vivien, Aurore Jambu, Patrice Berthaud, Axel Le Cesne, Jean-Yves Blay and Gilles Vassal
    Clin Cancer Res October 15 2006 12 (20) 6073-6078; DOI:10.1158/1078-0432.CCR-05-2596

  • Cancer Therapy: Clinical
    A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
    Shinichiro Motohashi, Aki Ishikawa, Eiichi Ishikawa, Mizuto Otsuji, Toshihiko Iizasa, Hideki Hanaoka, Naomi Shimizu, Shigetoshi Horiguchi, Yoshitaka Okamoto, Shin-ichiro Fujii, Masaru Taniguchi, Takehiko Fujisawa and Toshinori Nakayama
    Clin Cancer Res October 15 2006 12 (20) 6079-6086; DOI:10.1158/1078-0432.CCR-06-0114

  • Cancer Therapy: Clinical
    A Phase I Trial of Twice-Weekly 17-Allylamino-Demethoxy-Geldanamycin in Patients with Advanced Cancer
    Grzegorz S. Nowakowski, Andrea K. McCollum, Matthew M. Ames, Sumithra J. Mandrekar, Joel M. Reid, Alex A. Adjei, David O. Toft, Stephanie L. Safgren and Charles Erlichman
    Clin Cancer Res October 15 2006 12 (20) 6087-6093; DOI:10.1158/1078-0432.CCR-06-1015

  • Cancer Therapy: Clinical
    Hoosier Oncology Group Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
    Noah M. Hahn, Sharon Marsh, William Fisher, Robert Langdon, Robin Zon, Mark Browning, Cynthia S. Johnson, Tiffany J. Scott-Horton, Lang Li, Howard L. McLeod and Christopher J. Sweeney
    Clin Cancer Res October 15 2006 12 (20) 6094-6099; DOI:10.1158/1078-0432.CCR-06-1188

  • Cancer Therapy: Clinical
    Pharmacokinetics and Toxicity of Weekly Docetaxel in Older Patients
    Arti Hurria, Mark T. Fleming, Sharyn D. Baker, Wm. Kevin Kelly, Katie Cutchall, Katherine Panageas, James Caravelli, Henry Yeung, Mark G. Kris, Jorge Gomez, Vincent A. Miller, Gabriella D'Andrea, Howard I. Scher, Larry Norton and Clifford Hudis
    Clin Cancer Res October 15 2006 12 (20) 6100-6105; DOI:10.1158/1078-0432.CCR-06-0200

  • Cancer Therapy: Clinical
    A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
    Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Gang Wang, Zelig Eshhar, Sharon A. Mavroukakis, Donald E. White, John R. Wunderlich, Silvana Canevari, Linda Rogers-Freezer, Clara C. Chen, James C. Yang, Steven A. Rosenberg and Patrick Hwu
    Clin Cancer Res October 15 2006 12 (20) 6106-6115; DOI:10.1158/1078-0432.CCR-06-1183

  • Cancer Therapy: Clinical
    Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy
    Tateki Yoshino, Hiroaki Shiina, Shinji Urakami, Nobuyuki Kikuno, Tatsuaki Yoneda, Kazushi Shigeno and Mikio Igawa
    Clin Cancer Res October 15 2006 12 (20) 6116-6124; DOI:10.1158/1078-0432.CCR-06-0147

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics
    Jurjen S. Lagas, Maria L. Vlaming, Olaf van Tellingen, Els Wagenaar, Robert S. Jansen, Hilde Rosing, Jos H. Beijnen and Alfred H. Schinkel
    Clin Cancer Res October 15 2006 12 (20) 6125-6132; DOI:10.1158/1078-0432.CCR-06-1352

  • Cancer Therapy: Preclinical
    Piroxicam and Cisplatin in a Mouse Model of Peritoneal Mesothelioma
    Enrico P. Spugnini, Irene Cardillo, Alessandra Verdina, Stefania Crispi, Silvia Saviozzi, Raffaele Calogero, Angela Nebbioso, Lucia Altucci, Giancarlo Cortese, Rossella Galati, Jeremy Chien, Viji Shridhar, Bruno Vincenzi, Gennaro Citro, Francesco Cognetti, Ada Sacchi and Alfonso Baldi
    Clin Cancer Res October 15 2006 12 (20) 6133-6143; DOI:10.1158/1078-0432.CCR-06-1056

  • Cancer Therapy: Preclinical
    A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
    Tobias Martens, Nils-Ole Schmidt, Carmen Eckerich, Regina Fillbrandt, Mark Merchant, Ralph Schwall, Manfred Westphal and Katrin Lamszus
    Clin Cancer Res October 15 2006 12 (20) 6144-6152; DOI:10.1158/1078-0432.CCR-05-1418

  • Cancer Therapy: Preclinical
    Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors
    Jennifer D. Wu, Kathy Haugk, Ilsa Coleman, Lillie Woodke, Robert Vessella, Peter Nelson, R. Bruce Montgomery, Dale L. Ludwig and Stephen R. Plymate
    Clin Cancer Res October 15 2006 12 (20) 6153-6160; DOI:10.1158/1078-0432.CCR-06-0443

  • Cancer Therapy: Preclinical
    Effect of Simultaneous Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 in HER-2/Neu-Positive Breast Cancer
    Susan Lanza-Jacoby, Randy Burd, Francis E. Rosato Jr., Kandace McGuire, James Little, Noel Nougbilly and Sheldon Miller
    Clin Cancer Res October 15 2006 12 (20) 6161-6169; DOI:10.1158/1078-0432.CCR-06-0042

  • Cancer Therapy: Preclinical
    The Use of a Tropism-Modified Measles Virus in Folate Receptor–Targeted Virotherapy of Ovarian Cancer
    Kosei Hasegawa, Takafumi Nakamura, Mary Harvey, Yasuhiro Ikeda, Ann Oberg, Mariangela Figini, Silvana Canevari, Lynn C. Hartmann and Kah-Whye Peng
    Clin Cancer Res October 15 2006 12 (20) 6170-6178; DOI:10.1158/1078-0432.CCR-06-0992

  • Cancer Therapy: Preclinical
    Gene Therapy Using Adenovirus-Mediated Full-length Anti-HER-2 Antibody for HER-2 Overexpression Cancers
    Minghong Jiang, Wenfang Shi, Qi Zhang, Xinhua Wang, Minggao Guo, Zhenfu Cui, Changqin Su, Qing Yang, Yuemin Li, Jonathan Sham, Xinyuan Liu, Mengchao Wu and Qijun Qian
    Clin Cancer Res October 15 2006 12 (20) 6179-6185; DOI:10.1158/1078-0432.CCR-06-0746

  • Cancer Therapy: Preclinical
    Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
    Tai W. Wong, Francis Y. Lee, Chiang Yu, Feng R. Luo, Simone Oppenheimer, Hongjian Zhang, Richard A. Smykla, Harold Mastalerz, Brian E. Fink, John T. Hunt, Ashvinikumar V. Gavai and Gregory D. Vite
    Clin Cancer Res October 15 2006 12 (20) 6186-6193; DOI:10.1158/1078-0432.CCR-06-0642

Cancer Susceptibility and Prevention

  • Cancer Susceptibility and Prevention
    Grape Seed Extract Inhibits In vitro and In vivo Growth of Human Colorectal Carcinoma Cells
    Manjinder Kaur, Rana P. Singh, Mallikarjuna Gu, Rajesh Agarwal and Chapla Agarwal
    Clin Cancer Res October 15 2006 12 (20) 6194-6202; DOI:10.1158/1078-0432.CCR-06-1465

Letters to the Editor

  • Letters to the Editor
    The Activity of Sunitinib against Gastrointestinal Stromal Tumor Seems to be Distinct from Its Antiangiogenic Effects
    Marco Seandel, Jinru Shia, Irina Linkov, Robert G. Maki, Cristina R. Antonescu and Jakob Dupont
    Clin Cancer Res October 15 2006 12 (20) 6203-6204; DOI:10.1158/1078-0432.CCR-06-1292

  • Letters to the Editor
    Does MDR-1 G2677T/A Polymorphism Really Associate with Ovarian Cancer Response to Paclitaxel Chemotherapy?
    Agnieszka H. Ludwig and Jolanta Kupryjañczyk
    Clin Cancer Res October 15 2006 12 (20) 6204-6204; DOI:10.1158/1078-0432.CCR-06-1374

  • Letters to the Editor
    Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
    Maurice B. Loughrey, Paul M. Waring, Alex Dobrovic, George Demetri, Serge Kovalenko and Grant McArthur
    Clin Cancer Res October 15 2006 12 (20) 6205-6206; DOI:10.1158/1078-0432.CCR-06-1079

  • Letters to the Editor
    Polyclonal Resistance in Gastrointestinal Stromal Tumor Treated with Sequential Kinase Inhibitors
    Eva Wardelmann, Katharina Biermann, Sabine Merkelbach-Bruse, Hans-Ulrich Schildhaus, Nadja Thomas, Reinhard Büttner, Torsten Pietsch, Thomas Heinicke, Nicola Speidel, Daniel Pink, Peter Reichardt and Peter Hohenberger
    Clin Cancer Res October 15 2006 12 (20) 6206-6206; DOI:10.1158/1078-0432.CCR-06-1749

Advances in Treating Metastatic Bone Cancer

  • Advances in Treating Metastatic Bone Cancer
    Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference
    Allan Lipton, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Oyvind S. Bruland, Michael A. Carducci, Charles S. Cleeland, Denis R. Clohisy, Robert E. Coleman, Richard J. Cook, Theresa A. Guise, Roger N. Pearse, Trevor J. Powles, Michael J. Rogers, G. David Roodman, Matthew R. Smith, Larry J. Suva, Robert L. Vessella, Katherine N. Weilbaecher and Laura King
    Clin Cancer Res October 15 2006 12 (20) 6209s-6212s; DOI:10.1158/1078-0432.CCR-06-1213

  • Advances in Treating Metastatic Bone Cancer
    Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases
    Theresa A. Guise, Khalid S. Mohammad, Gregory Clines, Elizabeth G. Stebbins, Darren H. Wong, Linda S. Higgins, Robert Vessella, Eva Corey, Susan Padalecki, Larry Suva and John M. Chirgwin
    Clin Cancer Res October 15 2006 12 (20) 6213s-6216s; DOI:10.1158/1078-0432.CCR-06-1007

  • Advances in Treating Metastatic Bone Cancer
    Genomics and Proteomics of Bone Cancer
    Aaron G. Marguiles, V. Suzanne Klimberg, Sudeepa Bhattacharrya, Dana Gaddy and Larry J. Suva
    Clin Cancer Res October 15 2006 12 (20) 6217s-6221s; DOI:10.1158/1078-0432.CCR-06-1070

  • Advances in Treating Metastatic Bone Cancer
    Molecular Mechanisms of Action of Bisphosphonates: Current Status
    Anke J. Roelofs, Keith Thompson, Sharon Gordon and Michael J. Rogers
    Clin Cancer Res October 15 2006 12 (20) 6222s-6230s; DOI:10.1158/1078-0432.CCR-06-0843

  • Advances in Treating Metastatic Bone Cancer
    Biology of Bone Cancer Pain
    Michael J. Goblirsch, Pawel P. Zwolak and Denis R. Clohisy
    Clin Cancer Res October 15 2006 12 (20) 6231s-6235s; DOI:10.1158/1078-0432.CCR-06-0682

  • Advances in Treating Metastatic Bone Cancer
    The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience
    Charles S. Cleeland
    Clin Cancer Res October 15 2006 12 (20) 6236s-6242s; DOI:10.1158/1078-0432.CCR-06-0988

  • Advances in Treating Metastatic Bone Cancer
    Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
    Robert E. Coleman
    Clin Cancer Res October 15 2006 12 (20) 6243s-6249s; DOI:10.1158/1078-0432.CCR-06-0931

  • Advances in Treating Metastatic Bone Cancer
    High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities?
    Øyvind S. Bruland, Sten Nilsson, Darrell R. Fisher and Roy H. Larsen
    Clin Cancer Res October 15 2006 12 (20) 6250s-6257s; DOI:10.1158/1078-0432.CCR-06-0841

  • Advances in Treating Metastatic Bone Cancer
    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease
    Jean-Jacques Body
    Clin Cancer Res October 15 2006 12 (20) 6258s-6263s; DOI:10.1158/1078-0432.CCR-06-0840

  • Advances in Treating Metastatic Bone Cancer
    Multistate Analysis of Skeletal Events in Patients with Bone Metastases
    Richard J. Cook and Pierre Major
    Clin Cancer Res October 15 2006 12 (20) 6264s-6269s; DOI:10.1158/1078-0432.CCR-06-0654

  • Advances in Treating Metastatic Bone Cancer
    New Potential Targets for Treating Myeloma Bone Disease
    G. David Roodman
    Clin Cancer Res October 15 2006 12 (20) 6270s-6273s; DOI:10.1158/1078-0432.CCR-06-0845

  • Advances in Treating Metastatic Bone Cancer
    Wnt Antagonism in Multiple Myeloma: A Potential Cause of Uncoupled Bone Remodeling
    Roger N. Pearse
    Clin Cancer Res October 15 2006 12 (20) 6274s-6278s; DOI:10.1158/1078-0432.CCR-06-0648

  • Advances in Treating Metastatic Bone Cancer
    Treatment for Myeloma Bone Disease
    Howard S. Yeh and James R. Berenson
    Clin Cancer Res October 15 2006 12 (20) 6279s-6284s; DOI:10.1158/1078-0432.CCR-06-0681

  • Advances in Treating Metastatic Bone Cancer
    Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis
    Robert L. Vessella and Eva Corey
    Clin Cancer Res October 15 2006 12 (20) 6285s-6290s; DOI:10.1158/1078-0432.CCR-06-0813

  • Advances in Treating Metastatic Bone Cancer
    Src Inhibitors in Metastatic Bone Disease
    Brendan F. Boyce, Lianping Xing, Zhenqiang Yao, Teruhito Yamashita, William C. Shakespeare, Yihan Wang, Chester A. Metcalf III, Raji Sundaramoorthi, David C. Dalgarno, John D. Iuliucci and Tomi K. Sawyer
    Clin Cancer Res October 15 2006 12 (20) 6291s-6295s; DOI:10.1158/1078-0432.CCR-06-0991

  • Advances in Treating Metastatic Bone Cancer
    Targeting Bone Metastasis in Prostate Cancer with Endothelin Receptor Antagonists
    Michael A. Carducci and Antonio Jimeno
    Clin Cancer Res October 15 2006 12 (20) 6296s-6300s; DOI:10.1158/1078-0432.CCR-06-0929

  • Advances in Treating Metastatic Bone Cancer
    Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer
    Trevor Powles, Eugene McCroskey and Alexander Paterson
    Clin Cancer Res October 15 2006 12 (20) 6301s-6304s; DOI:10.1158/1078-0432.CCR-06-1211

  • Advances in Treating Metastatic Bone Cancer
    Future Treatment of Bone Metastases
    Allan Lipton
    Clin Cancer Res October 15 2006 12 (20) 6305s-6308s; DOI:10.1158/1078-0432.CCR-06-1157

  • Advances in Treating Metastatic Bone Cancer
    Skeletal Complications of Breast Cancer Therapies
    Angela Hirbe, Elizabeth A. Morgan, Özge Uluçkan and Katherine Weilbaecher
    Clin Cancer Res October 15 2006 12 (20) 6309s-6314s; DOI:10.1158/1078-0432.CCR-06-0652

  • Advances in Treating Metastatic Bone Cancer
    Treatment-Related Osteoporosis in Men with Prostate Cancer
    Matthew R. Smith
    Clin Cancer Res October 15 2006 12 (20) 6315s-6319s; DOI:10.1158/1078-0432.CCR-06-0846

Back to top
PreviousNext
Clinical Cancer Research: 12 (20)
October 2006
Volume 12, Issue 20
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Biological Role of Estrogen Receptor β in Salivary Gland Adenocarcinoma Cells
  • Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study
  • Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics
  • Gene Therapy Using Adenovirus-Mediated Full-length Anti-HER-2 Antibody for HER-2 Overexpression Cancers

Jump to

  • Editorial
  • The Biology Behind
  • Molecular Pathways
  • Special Article
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Cancer Susceptibility and Prevention
  • Letters to the Editor
  • Advances in Treating Metastatic Bone Cancer
Advertisement
  • Most Cited
  • Most Read
Loading
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • FLASH-RT Spares Lung Progenitor Cells
  • AR Gene Rearrangements in Prostate Cancer
  • PDAC and GATA6 Expression
  • Guadecitabine and Carboplatin in Ovarian Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement